wla(warner lambert) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : wla(warner lambert)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: GP Kavanaugh who wrote (726)	5/3/1999 6:13:00 PM
From: John Carragher	Read Replies (2) of 942

Dow Jones Newswires Parke-Davis: Lipitor Lowers Cholesterol Levels In Women Dow Jones Newswires MORRIS PLAINS, N.J. -- A study conducted by Parke-Davis Canada showed women who use Lipitor, a cholesterol-lowering drug, had LDL cholesterol to target levels. Parke-Davis Canada is a unit of Warner-Lambert Co.'s (WLA) and Pfizer Inc.'s (PFE) Canadian units. In a press release Friday, Parke-Davis said the 16-week, 318-patient study showed that 87% of women with two or more risk factors for coronary heart disease reached target LDL cholesterol levels. In addition, 81% of women with established coronary heart disease reached target LDL cholesterol levels. Parke-Davis makes and markets pharmaceutical products.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next